NASDAQ:EQ

Equillium Stock Predictions

etoro logo Buy EQ
*Your capital is at risk
$3.11
+0.320 (+11.47%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

EQ Prediction Chart

EQ Predictions History

Latest community submissions for EQ.
Predictor Target Session Target Price Result Direction Accuracy Score
Feb 2, 2026 $1.37 -3.86% $1.51 X 90.41% 0
Feb 2, 2026 $1.39 -2.41% $1.51 X 91.77% 0
Feb 2, 2026 Bullish $1.51 V 1
Feb 2, 2026 Bullish $1.51 V 1
Jan 26, 2026 $1.21 -4.40% $1.22 V 99.52% 5
Jan 26, 2026 $1.24 -2.75% $1.22 V 98.76% 2
Jan 26, 2026 $1.47 +15.75% $1.22 X 79.51% 0
Jan 20, 2026 $1.09 -5.48% $1.15 X 94.52% 0
Jan 20, 2026 $1.11 -3.43% $1.15 X 96.57% 0
Jan 20, 2026 Bullish $1.15 X 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for EQ with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT EQUILLIUM INC.
Equillium
Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which is in Phase III clinical trials for the treatment of acute graft-versus-host disease; completed Phase Ib...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE